MindMaze Therapeutics RLFTY Stock
MindMaze Therapeutics Price Chart
MindMaze Therapeutics RLFTY Financial and Trading Overview
| MindMaze Therapeutics stock price | 0.17 USD |
| Previous Close | 0.23 USD |
| Open | 0.23 USD |
| Bid | 0.32 USD x 1000000 |
| Ask | 2.79 USD x 155000 |
| Day's Range | 0.23 - 0.23 USD |
| 52 Week Range | 0.23 - 4.05 USD |
| Volume | 2.5K USD |
| Avg. Volume | 42 USD |
| Market Cap | 39.25M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RLFTY Valuation Measures
| Enterprise Value | 33.95M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 32.819027 |
| Price/Book (mrq) | 0.9128098 |
| Enterprise Value/Revenue | 28.388 |
| Enterprise Value/EBITDA | -3.32 |
Trading Information
MindMaze Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -84.60% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 4.05 USD |
| 52 Week Low | 0.23 USD |
| 50-Day Moving Average | 0.95 USD |
| 200-Day Moving Average | 1.27 USD |
RLFTY Share Statistics
| Avg. Volume (3 month) | 42 USD |
| Avg. Daily Volume (10-Days) | 250 USD |
| Shares Outstanding | 169.99M |
| Float | 51.25M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1144.71% |
| Gross Margin | 90.38% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.2M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | 1731.29% |
| Gross Profit (ttm) | 1.08M USD |
| EBITDA | -10227000 USD |
| Net Income Avi to Common (ttm) | -10075000 USD |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.32M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 24K USD |
| Total Debt/Equity (mrq) | 0.07 USD |
| Current Ratio (mrq) | 1.398 |
| Book Value Per Share (mrq) | 0.25295523 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13509000 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of MindMaze Therapeutics
| Country | United States |
| State | N/A |
| City | Geneva |
| Address | Avenue de Sécheron 15 |
| ZIP | 1202 |
| Phone | 41 21 552 08 01 |
| Website | https://mindmazetherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Q&A For MindMaze Therapeutics Stock
What is a current RLFTY stock price?
MindMaze Therapeutics RLFTY stock price today per share is 0.17 USD.
How to purchase MindMaze Therapeutics stock?
You can buy RLFTY shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MindMaze Therapeutics?
The stock symbol or ticker of MindMaze Therapeutics is RLFTY.
Which industry does the MindMaze Therapeutics company belong to?
The MindMaze Therapeutics industry is Biotechnology.
How many shares does MindMaze Therapeutics have in circulation?
The max supply of MindMaze Therapeutics shares is 169.98M.
What is MindMaze Therapeutics Price to Earnings Ratio (PE Ratio)?
MindMaze Therapeutics PE Ratio is now.
What was MindMaze Therapeutics earnings per share over the trailing 12 months (TTM)?
MindMaze Therapeutics EPS is -0.32 USD over the trailing 12 months.
Which sector does the MindMaze Therapeutics company belong to?
The MindMaze Therapeutics sector is Healthcare.
